BioMarin's New Rare-Disease Med Costs More Than Expected [Investor's Business Daily]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Investors Business Daily
Related news 8:01 AM ET Check the Stock Market Today column to spot changes in market trend and track the best stocks to buy and... Why Analysts Remain Bullish On This Hemophilia Gene-Therapy Play The FDA Is Trying To 'Shame' Celgene, Gilead — Here's Why It Won't Work Why Hemophilia Patients Could Pay $1.5 Million For Gene Therapy Roche Hashes Out Details Of Patient Deaths In Hemophilia Drug Is This Biotech Hedging Its 2018 Outlook On A Key FDA Approval? Biotech Stock Rockets To Record On Gene Therapy Trial In Children The FDA Just Blessed A Hemophilia Trial From This Biotech Biotech Stocks Soar On Trial Data At Hematology Conference BioMarin Pharmaceutical ( BMRN ) jumped to a 16-week high Friday after it gained approval for a rare-disease drug and priced it higher than analysts expected. Late Thursday, the Food and Drug Administration approved Palynziq to treat a disorder in which the amino acid phenylalanine builds up in the body. P
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- AAV Vectors in Gene Therapy Pipeline Landscape Report 2024: Comprehensive Insights about 70+ Companies and 235+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
- World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"PR Web
- World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders" [Yahoo! Finance]Yahoo! Finance
- First clinical trial of vosoritide for children with hypochondroplasia shows increased growth [Yahoo! Finance]Yahoo! Finance
- BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ETPR Newswire
BMRN
Earnings
- 2/22/24 - Beat
BMRN
Sec Filings
- 4/15/24 - Form 4
- 4/12/24 - Form 4
- 4/12/24 - Form 144
- BMRN's page on the SEC website